Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sirolimus pilot study in severe intestinal polyposis in familial adenomatous polyposis
NL-OMON47156Phase 2Active, not recruiting
- Sponsor
- Amsterdam University Medical Center
- Start
- Oct 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of sirolimus in Colonic Adenomatous Polyposis and familial adenomatous polyposis (FAP), sponsored by Amsterdam University Medical Center. Primary endpoints: Size of 5 marked polyps and Safety. Started Oct 2017; status: active, not recruiting.
02
Drugs
sirolimus
03
Conditions
Colonic Adenomatous Polyposisfamilial adenomatous polyposis (FAP)
Beyond the preview
Go deeper on NL-OMON47156.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON47156.